Targeting Nuclear LSD1 to Reprogram Cancer Cells and Reinvigorate Exhausted T Cells via a Novel LSD1-EOMES Switch.
Tu, W.J., McCuaig, R.D., Tan, A.H.Y., Hardy, K., Seddiki, N., Ali, S., Dahlstrom, J.E., Bean, E.G., Dunn, J., Forwood, J., Tsimbalyuk, S., Smith, K., Yip, D., Malik, L., Prasanna, T., Milburn, P., Rao, S.(2020) Front Immunol 11: 1228